Non-surgical approach to small cell carcinoma of the esophagus: does this rare disease have the same tumor behavior as SCLC?
- 27 October 2011
- journal article
- Published by Springer Science and Business Media LLC in International Journal of Clinical Oncology
- Vol. 17 (6), 610-615
- https://doi.org/10.1007/s10147-011-0332-1
Abstract
We conducted a retrospective analysis to clarify the clinical profile of a nonsurgical approach to small cell carcinoma of the esophagus (SCEC). SCEC patients in our database were reviewed. Consistent with the standard approach to small cell carcinoma of the lung (SCLC), chemoradiotherapy was the first choice for limited disease (LD)-SCEC in our institution while chemotherapy was the first choice for extensive disease (ED)-SCEC. Our strategy did not include prophylactic cranial irradiation. Eighteen patients were treated between January 1996 and December 2006, of whom 10 had LD-SCEC and 8 had ED-SCEC. Regarding response to chemoradiotherapy in patients with LD-SCEC, CR rate at the primary site was 90% (9/10) and total CR rate was 80% (8/10). With a median follow-up period of 55.3 months, median survival time in LD-SCEC and ED-SCEC patients was 17.3 and 13.9 months, respectively, showing no significant difference (p = 0.57). Brain metastases occurred in only one patient. On follow-up, eight patients with LD-SCEC and seven with ED-SCEC died of disease. Only 2 patients died of local progression, while the remaining 13 died of disease progression of distant metastases. Despite providing good local control, chemoradiotherapy appeared to have insufficient potential to cure LD-SCEC. Prophylactic brain irradiation for SCEC is unnecessary.Keywords
This publication has 20 references indexed in Scilit:
- Small Cell Carcinoma of the Esophagus: A Report of 16 Cases From a Single Institution and Literature ReviewThe Annals of Thoracic Surgery, 2011
- OPTIMAL TIMING OF ENDOSCOPIC EVALUATION OF THE PRIMARY SITE OF ESOPHAGEAL CANCER AFTER CHEMORADIOTHERAPY OR RADIOTHERAPY: A RETROSPECTIVE ANALYSISDigestive Endoscopy, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal Of Cancer, 2009
- Small-cell carcinoma of the esophagus and gastroesophageal junction: review of the Memorial Sloan-Kettering experienceAnnals Of Oncology, 2007
- Prophylactic Cranial Irradiation in Extensive Small-Cell Lung CancerNew England Journal of Medicine, 2007
- Small cell oesophageal carcinoma: an institutional experience and review of the literatureBritish Journal of Cancer, 2007
- Randomized Phase III Trial Comparing Irinotecan/Cisplatin With Etoposide/Cisplatin in Patients With Previously Untreated Extensive-Stage Disease Small-Cell Lung CancerJournal of Clinical Oncology, 2006
- Small-Cell Carcinomas of the Gastrointestinal Tract: A ReviewJournal of Clinical Oncology, 2004
- Primary small-cell cancer of the esophagusThe Journal of Thoracic and Cardiovascular Surgery, 1995
- Oat‐cell carcinoma of the œsophagusThe Journal of Pathology and Bacteriology, 1952